期刊文献+

甲巯咪唑和地塞米松对Graves甲亢患者白细胞糖皮质激素受体、血浆ACTH及皮质醇的影响 被引量:5

Effect of Methimazole and Dexamethasone on Leucocyte Glucocorticoid Receptor,Plasma ACTH,and Cortisol Levels in Graves′Disease
下载PDF
导出
摘要 研究了32例Graves甲亢(甲亢)患者单用甲巯咪唑及联用地塞米松(Dex)治疗前后白细胞糖皮质激素受体(GCR),血浆皮质醇(PTC)和血浆ACTH的变化。开始甲巯咪唑40mg/d,两周后减至20mg/d,直至完全缓解。联用Dex组除甲巯咪唑外,开始加Dex6mg/d,第5日减至4.5mg/d,两周后减至2.25mg/d,直至完全缀解。结果发现,未治甲亢患者的白细胞GCR水平显著降低,PTC略降、ACTH轻度升高,提示甲亢时垂体-肾上腺轴机能处于代偿状态。单用甲巯咪唑组治疗后病情缓解,GCR、ACTH及PTC恢复正常。联用甲巯咪唑及Dex组治疗后,GCR、ACTH及PTC均显著降低,揭示GCR呈下降调节,同时垂体-肾上腺轴受外源性Dex抑制。因此,甲亢患者使用糖皮质类固醇治疗时应注意调整剂量,以避免由于垂体-肾上腺轴受抑制在应激时发生肾上腺皮质功能不全。 Thirty-two cases of newly diagnosedGraves’disease with hyperthyroidism were recruited inthis study on the changes of leucocyte glucocorticoidreceptor(GCR),plasma ACTH,and cortisol levelshbrand after treatment with methinazole(tapazole)alone (n=16)and methimazole combined with Dexam-ethasone(bex,TD group,n=16).Twenty normalsserved as the control.Methimazole treatment was initiated with a dosage of 40 mg/d,tapered to 20 mg/d after twoweeks and maintained until complete remission in bothgroups. Meanwhile, Dex 6 mg/d was added to the TDgroup along with methimazole from the commence-ment of therapy. The dosage of bex was reduced to4.5mg/d on the 5th day and to 2.25 mg/d two weeksafter treatment, and continued until remission.It wasfound that there was remarkable decrease in leucocyteGCR levels with a moderate elevation of plasmaACTH and a slight decline of plasma cortisol in un-treated Graves’disease,suggestive of a compensationof the pituitary-adrenal axis function in hyperthy-roidism. The levels of GCR,ACTH and cortisol re-turned to normal after complete ren1ission by methima-zole in the methimazole alone group. In the TD group,however.all GcR .ACTH and cortisol levels weresignificantly decreased after Dex therapy implyingdown regulation of GCR by exogenous Dex and sup-presion of the pituitary-adrenal axis. Thus the dosageof glucocorticoid should be appropriately adjusted toavoid adrenal insufficiency,especiall y in case ofstress,due to the suppresion of pituitary adrenal func-tion.
出处 《华西医科大学学报》 CSCD 1996年第1期75-78,共4页 Journal of West China University of Medical Sciences
关键词 GRAVES病 GC 甲巯咪唑 地塞米松 药物疗法 Methimazole(tepazole)Dexamethasone Graves’disease Glucocorticoid receptor pituitaryadrenal axisMedical gtaduate Present Address:Hainan Provincial Hospital
  • 相关文献

参考文献3

  • 1刘志民,第二届全军内分泌代谢专业学术会议资料汇编,1987年
  • 2王寅章,中华内分泌代谢杂志,1987年,3卷,151页
  • 3田英,中华核医学杂志,1986年,2卷,209页

同被引文献33

  • 1Cavalieri RR. Effect of dexamethasone on kinetics and distribution of triiodothyronine in the rat. Endocrinology, 1984,114:215.
  • 2Croxon MS, Hall TD, Nicoloff JT. Combination drug therapy for treatment of hyperthyroid Graves' disease. J Clin Endocrinol Metab, 1997,45:623.
  • 3汪明性,扬震寰,叶雨文,等.药理学.第2版.北京:人民卫生出版社,1984,291.
  • 4Degroot LJ, Larsen PR, Refetoff, et al. The thyroid and Its disease. 5th ed. New York: John Willey and Sons, 1984,128-399.
  • 5Wener SC, Platman SR. Remission of hyperthyroidism(Graves' disease) pattem of serum-thyroxine binding induced by predinisone. Lancet,1965,(2):751.
  • 6高勇义、张存泓、李秀钧 等.并用他巴唑和地塞米松治疗Graves病临床疗效观察[J].中国基层医学杂志,1995,2(3):134-135.
  • 7高勇义 许少刚 陈道雄.单用地塞米松对Graves甲亢的初步探讨[J].中国药房,1995,(1):191-193.
  • 8Chopra IJ, Willians DE, Orgizzi J, et al. Opposite effects of dexamethasone on serum concentration of 3' 5'-triiodothyronine(reverseT3), 3'5'-triiodothyronine(t3) J Clin Endocrinol Metab, 1975, 41:911.
  • 9Gomez-Balaguer M. Effect of dexamethasone on T3, T4, THS and PRL plasmatic levels in normal subjects. J Steroid Biochem, 1986,17(Suppl):44.
  • 10赵岚.糖尿病并发肺结核患者甲状腺激素测定及临床意义[J].陕西医学杂志,2007,36(9):1222-1224. 被引量:8

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部